# the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients

> **NCT06736184** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Kidney Disease on Hemodialysis
- Hypokalemia
- Hyperkalemia
- Myocardial Injury

## Interventions

- **DRUG:** Sodium Zirconium Cyclosilicate (SZC)

## Key facts

- **NCT ID:** NCT06736184
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06736184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06736184, "the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06736184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*